ethosuximide

Generic: ethosuximide

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ethosuximide
Generic Name ethosuximide
Labeler chartwell rx, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ethosuximide 250 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-790
Product ID 62135-790_24119078-bcee-0aa9-e063-6394a90af9c8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200892
Listing Expiration 2026-12-31
Marketing Start 2015-09-09

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135790
Hyphenated Format 62135-790

Supplemental Identifiers

RxCUI
197682
UPC
0362135790127
UNII
5SEH9X1D1D
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ethosuximide (source: ndc)
Generic Name ethosuximide (source: ndc)
Application Number ANDA200892 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 120 CAPSULE in 1 BOTTLE (62135-790-12)
source: ndc

Packages (1)

62135-790-12 120 CAPSULE in 1 BOTTLE (62135-790-12)

Ingredients (1)

ethosuximide (250 mg/1)

Linked Drug Pages (1)

ETHOSUXIMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "24119078-bcee-0aa9-e063-6394a90af9c8", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0362135790127"], "unii": ["5SEH9X1D1D"], "rxcui": ["197682"], "spl_set_id": ["43fdfd16-c723-452a-9c1d-accf6f7c622e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (62135-790-12)", "package_ndc": "62135-790-12", "marketing_start_date": "20231023"}], "brand_name": "ETHOSUXIMIDE", "product_id": "62135-790_24119078-bcee-0aa9-e063-6394a90af9c8", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62135-790", "generic_name": "ETHOSUXIMIDE", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHOSUXIMIDE", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/1"}], "application_number": "ANDA200892", "marketing_category": "ANDA", "marketing_start_date": "20150909", "listing_expiration_date": "20261231"}